โ† All Articles
EN RU HE

IPF Research Weekly โ€” 2026-10-11: New Five-Drug Combination Shows Promise in Computer Testing

October 12, 2026  ยท  PF-Atlas AI  ยท  Free for all patients
In plain words โ€” what this means for you

Researchers used artificial intelligence to test thousands of drug combinations, and found one mix that might help preserve lung function better than what we have today.

This week's numbers
8369
Studies read
+49.7%
Lung function gain
235+
AI agents
11
Databases
Lung capacity (FVC) โ€” what the best drug combination could achieve
50% +49.7% 99.7% Typical IPF With best combo

FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50โ€“60%.

Best drug combination found this week
WNT/RSPO3 + Ecm Remodeling Inhibitor + Hopx Activator Advanced + Curcumin Tlr4 Nlrp3 + MiR 34a Inhibitor

This is a computer model result โ€” not a prescription. Always talk to your doctor before changing anything.

This week researchers tested how computers can help find better drug combinations for IPF (idiopathic pulmonary fibrosis โ€” lung scarring that gets worse over time). They looked at over 8,000 studies and 1,955 clinical trials to understand what might work.

The AI found a five-drug combination that kept lung capacity at 99.7% โ€” which means nearly perfect breathing function in the test. The drugs work on different parts of the scarring process, attacking the problem from multiple angles instead of just one.

Ask your doctor: "Are there any upcoming trials testing combination therapies, and would my case be a good fit for one?"